Cancer Targeted Technology

About Cancer Targeted Technology

Cancer Targeted Technology is focused on designing and patenting small molecule drugs for cancer, with unique diagnostic imaging and therapeutic properties to diagnose and treat cancer more effectively.

Products & Services

CTT1057:A PET Imaging Agent for Prostate Cancer, used for diagnostic purposes.

CTT1403:A Radiotherapeutic drug for Prostate Cancer, aimed at therapeutic treatment.

Specialties

Cancer Diagnostics Cancer Therapeutics Small Molecule Drugs Prostate Cancer Treatment PET Imaging Radiotherapy Chemotherapy

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: SBIR Grant T: - FT: SBIR Grant	A: 2400000 MR: - FA: $2.4 million FAN: 2400000	D: 2024-11-18 FD: 2024-11-18	1 investors

SBIR Grant Latest

2024-11-18

$2.4M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

H

Henry VanBrocklin

Professor in Residence and Director of the Radiopharmaceutical Research Program at the University of California, San Francisco; Joint Faculty Scientist at the Lawrence Berkeley National Laboratory

R

Rahul Aggarwal

Professor of Medicine

S

Spencer Behr

Associate Professor of Clinical Radiology

C

Carolyn Anderson

Simon-Ellebracht Professor in Medicinal Chemistry and Professor of Radiology

B

Beatrice Langton-Webster

Chief Executive Officer and Director

C

Clifford Berkman

Founder and Director

View 4 more team members with Pro

Unlock Full Team Directory

Recent News